ATYR
Price
$0.84
Change
+$0.02 (+2.44%)
Updated
Oct 7 closing price
Capitalization
81.95M
29 days until earnings call
SLXN
Price
$4.02
Change
+$0.16 (+4.15%)
Updated
Oct 8, 11:56 AM (EDT)
Capitalization
12.07M
Interact to see
Advertisement

ATYR vs SLXN

Header iconATYR vs SLXN Comparison
Open Charts ATYR vs SLXNBanner chart's image
aTyr Pharma
Price$0.84
Change+$0.02 (+2.44%)
Volume$5.66M
Capitalization81.95M
Silexion Therapeutics
Price$4.02
Change+$0.16 (+4.15%)
Volume$559
Capitalization12.07M
ATYR vs SLXN Comparison Chart in %
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATYR vs. SLXN commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATYR is a Hold and SLXN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 08, 2025
Stock price -- (ATYR: $0.84 vs. SLXN: $3.86)
Brand notoriety: ATYR and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATYR: 45% vs. SLXN: 12%
Market capitalization -- ATYR: $81.95M vs. SLXN: $12.07M
ATYR [@Biotechnology] is valued at $81.95M. SLXN’s [@Biotechnology] market capitalization is $12.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATYR’s FA Score shows that 0 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • ATYR’s FA Score: 0 green, 5 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATYR and SLXN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATYR’s TA Score shows that 6 TA indicator(s) are bullish while SLXN’s TA Score has 5 bullish TA indicator(s).

  • ATYR’s TA Score: 6 bullish, 5 bearish.
  • SLXN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both ATYR and SLXN are a good buy in the short-term.

Price Growth

ATYR (@Biotechnology) experienced а +15.93% price change this week, while SLXN (@Biotechnology) price change was +13.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was +15.97%, and the average quarterly price growth was +89.17%.

Reported Earning Dates

ATYR is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATYR($81.9M) has a higher market cap than SLXN($12.1M). ATYR YTD gains are higher at: -76.898 vs. SLXN (-87.197). SLXN has higher annual earnings (EBITDA): -17.81M vs. ATYR (-68.89M). ATYR has more cash in the bank: 80.3M vs. SLXN (3.47M). SLXN has less debt than ATYR: SLXN (3.7M) vs ATYR (12.7M). ATYR (0) and SLXN (0) have equivalent revenues.
ATYRSLXNATYR / SLXN
Capitalization81.9M12.1M677%
EBITDA-68.89M-17.81M387%
Gain YTD-76.898-87.19788%
P/E RatioN/AN/A-
Revenue00-
Total Cash80.3M3.47M2,317%
Total Debt12.7M3.7M343%
FUNDAMENTALS RATINGS
ATYR: Fundamental Ratings
ATYR
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
99
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATYRSLXN
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
12%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
30%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
37%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
28%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
56%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 8 days ago
53%
Declines
ODDS (%)
Bearish Trend 8 days ago
83%
Bearish Trend 1 day ago
78%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
50%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KGS34.520.97
+2.89%
Kodiak Gas Services
BTBD1.880.03
+1.62%
BT Brands
TOST37.170.22
+0.60%
Toast
ARVN9.30-0.32
-3.33%
Arvinas
GSIT4.62-0.20
-4.15%
GSI Technology

ATYR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with AMLX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
+1.42%
AMLX - ATYR
39%
Loosely correlated
+6.30%
IDYA - ATYR
39%
Loosely correlated
-2.07%
SLDB - ATYR
39%
Loosely correlated
+0.73%
NTLA - ATYR
38%
Loosely correlated
-0.49%
CRNX - ATYR
37%
Loosely correlated
+1.97%
More